AHIMA September 21, 2020
The Medicare hospital inpatient prospective payment system (IPPS) final rule for fiscal year (FY) 2021 was published in the September 18 issue of the Federal Register. This final rule is effective October 1, 2020. AHIMA submitted comments on the IPPS proposed rule.
Key MS-DRG changes are described below.
Chimeric Antigen Receptor (CAR) T-cell Immunotherapies
A new MS-DRG (MS-DRG 018) was created specifically for Chimeric Antigen Receptor (CAR) T-cell immunotherapies. This MS-DRG includes cases that report ICD-10-PCS procedure codes XW033C3 (Introduction of engineered autologous chimeric antigen receptor t-cell immunotherapy into peripheral vein, percutaneous approach, new technology group 3) or XW043C3 (Introduction of engineered autologous chimeric antigen receptor t-cell immunotherapy into central vein, percutaneous approach, new technology group 3). CAR T-cell therapies...
Today's Sponsors
Today's Sponsor